Abattis Bioceuticals provides integrated solutions for cannabis-based and natural formulations, extracts and products, with a focus on health and wellness issues. Through its operations and wholly owned subsidiaries, the Company has a broad range of capabilities including: cultivating; licensing and marketing proprietary ingredients; bio-similar compounds; and patented equipment and consulting services to medicinal marijuana markets in North America. The Company has developed over 150 custom formulations and continues to break new ground in testing standards.
|52 Week High||$0.94|
|52 Week Low||$0.10|
|Abattis Bioceuticals Celebrates Legalization||2018-10-18|
|Abattis Bioceuticals Provides Update on Vaporizer Product Line||2018-10-11|
|Abattis Bioceuticals Provides Phase 1 Update on Research and Development||2018-10-04|
|Abattis Unveils "Comfort", Its Proprietary New Chronic Pain and Inflammation Product||2018-09-24|
|Abattis Strengthens Management Team and Provides Company Updates||2018-09-11|